Indications
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Composition
- Active substance
- insulin glargine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ondibta
- Active substance
- insulin glargine
- ATC code
- A10AE04
- Therapeutic area
- Diabetes Mellitus
- Marketing authorisation holder
- Gan & Lee Pharmaceuticals Europe GmbH
- Status
- Authorised
- EU authorisation
- 9 Jan 2026
- EMA product number